Gmez-ManzoSTerrn-HernndezJDe la Mora-De la MoraIGonzlez-ValdezAMarcial-QuinoJGarca-TorresIet alThe stability of G6PD is affected by mutations with different clinical phenotypes
Douglas DiGiorno has joined Wells Fargo Advisors' traditional brokerage channel, bringing more than $466 million in assets and three decades of industry experience
Poster Session I - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P480 - ESOC25-1882 CIRCULATING LNCRNAS AS POTENTIAL BIOMARKERS OF HAEMATOMA GROWTH IN INTRACEREBRAL HAEMORRHAGE: A PILOT STUDY Maria Lucas-Parra 1 , Carme Gubern-Mrida 1 , Carla Herminia Vera Caceres 2 , Dolors Puigoriol Illamola 1 , Laia Carballo-Perich 1 , Mikel Terceo 3 , Saima Bashir Viturro 1,2 , Toms Xucl-Ferrarons 1,2 , Vctor Vera-Monge 2 , Alan Murillo 2 , Juan Alvarez-Cienfuegos 1,2 , Isabel Vielba 2 , Elisabet Ortiz Martos 2 , Joaquin Serena 1,2 , Yolanda Silva 1,2 1 Institut dInvestigaci Biomdica de Girona (IDIBGI), Cerebrovascular Pathology group, Salt, Spain, 2 Hospital Universitari Dr

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around your inherited predispositions in metabolic pathways that intersect with antioxidant capacity and oxidative stress resilience